Mache dechanj, echanj stock jodi a
Stock quotes de 71229 konpayi nan tan reyèl.
Mache dechanj, echanj stock jodi a

Stock quotes

Stock quotes sou entènèt

Stock quotes istwa

Mache dechanj majiskil

Dividann Stock

Pwofi nan aksyon konpayi

Rapò finansye

Rating aksyon nan konpayi yo. Ki kote envesti lajan?

Catalyst Pharmaceuticals, Inc. bouchon mache

Volim nan komès stock Catalyst Pharmaceuticals, Inc. jodi a ak istwa a nan lèt majiskil nan Catalyst Pharmaceuticals, Inc. Depi nan kòmansman an nan komès nan CPRX aksyon sou echanj la machandiz.
Add to widgets
Te ajoute nan widgets

Catalyst Pharmaceuticals, Inc. lèt majiskil

Jodi a lèt majiskil sou mache a nan Catalyst Pharmaceuticals, Inc. se 1 750 580 992 US dola.
-10 756 864 $ (-0.61%)
chanjman nan lèt majiskil depi yè

Catalyst Pharmaceuticals, Inc. majiskil mete ajou yon fwa nan yon jounen. Sòm nan tout Catalyst Pharmaceuticals, Inc. pri stock bay jodi a se lèt majiskil nan Catalyst Pharmaceuticals, Inc. stock stock. Catalyst Pharmaceuticals, Inc. lèt majiskil se enfòmasyon louvri. Catalyst Pharmaceuticals, Inc. mache kap jodi a egal a 1 750 580 992 dola ameriken.

Catalyst Pharmaceuticals, Inc. volim nan komès

Jodi a volim nan komès de aksyon Catalyst Pharmaceuticals, Inc. montan 312 439 US dola.
-1 369 734 $ (-81.43%)
chanjman nan volim nan komès depi yè

Catalyst Pharmaceuticals, Inc. volim komès jodi a se 312 439 dola ameriken. Catalyst Pharmaceuticals, Inc. te fè kòmès sou echanj valè diferan. Catalyst Pharmaceuticals, Inc. komès holds sou anpil echanj valè echanj nan tan reyèl, nou montre volim komès la chak jou nan Catalyst Pharmaceuticals, Inc.. Catalyst Pharmaceuticals, Inc. kap mache desann.

Montre:
Pou

Catalyst Pharmaceuticals, Inc. mache bouchon tablo

Catalyst Pharmaceuticals, Inc. lèt majiskil sou yon graf pa ane. 2.98% - yon chanjman nan lèt majiskil sou mache Catalyst Pharmaceuticals, Inc. pou chak semèn. Chanjman nan majiskil Catalyst Pharmaceuticals, Inc. pou chak mwa se 0%. Catalyst Pharmaceuticals, Inc., majiskil kounye a - 1 750 580 992 dola ameriken.

Semèn Mwa 3 mwa Ane 3 zan

Catalyst Pharmaceuticals, Inc. Istwa kapitalizasyon

Dat Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
03/05/2023 1 750 580 992 $
02/05/2023 1 761 337 856 $
01/05/2023 1 760 807 808 $
28/04/2023 1 668 077 952 $
27/04/2023 1 670 197 504 $
26/04/2023 1 688 350 848 $
25/04/2023 1 699 972 864 $

Catalyst Pharmaceuticals, Inc. tablo volim

Semèn Mwa 3 mwa Ane 3 zan

Catalyst Pharmaceuticals, Inc. done istwa volim

Dat Volim (24h)
Volim komèsyal de aksyon Catalyst Pharmaceuticals, Inc. se kantite total tout tranzaksyon ak aksyon CPRX achte ak vann pandan dat la chwazi a.
03/05/2023 312 439 $
02/05/2023 1 682 173 $
01/05/2023 573 514 $
28/04/2023 262 782 $
27/04/2023 1 373 506 $
26/04/2023 308 871 $
25/04/2023 1 289 559 $

03/05/2023 Catalyst Pharmaceuticals, Inc. majiskil egal a 1 750 580 992 dola ameriken. Catalyst Pharmaceuticals, Inc. majiskil egal a 1 761 337 856 dola ameriken nan 02/05/2023. Sou 01/05/2023, Catalyst Pharmaceuticals, Inc. lèt majiskil mache a te $ 1 760 807 808. Catalyst Pharmaceuticals, Inc. majiskil nan 28/04/2023 montan pou 1 668 077 952 dola ameriken.

Catalyst Pharmaceuticals, Inc. mache majiskil nan 27/04/2023 egal a 1 670 197 504 dola ameriken. Catalyst Pharmaceuticals, Inc. majiskil nan 26/04/2023 montan pou 1 688 350 848 dola ameriken. Catalyst Pharmaceuticals, Inc. mache majiskil nan 25/04/2023 egal a 1 699 972 864 dola ameriken.

Lèt majiskil Catalyst Pharmaceuticals, Inc. jodi a se 1 750 580 992 $. Kapitalizasyon sou mache a nan Catalyst Pharmaceuticals, Inc. te chanje a -0.611% konpare ak yè. Volim komèsyal de aksyon CPRX nan Catalyst Pharmaceuticals, Inc. nan dènye jou komès montan pou 312 439 $. Volim komèsyal de aksyon de Catalyst Pharmaceuticals, Inc. chanje pou -81.426% konpare ak jou komès anvan an.

Pri a de aksyon Catalyst Pharmaceuticals, Inc.

Finans Catalyst Pharmaceuticals, Inc.